Vericel Corp cotiza a 40.62 USD y tiene una capitalización bursátil de $2.1B. En los últimos 12 meses ha facturado $306M con un margen de flujo de caja libre del 9.0%. Cotiza a 33.7 veces su flujo de caja libre (P/FCF) y a un PER de 85.9. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising …
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.04 | $-0.12 | $0.45 |
| Estimado | $0.06 | $-0.03 | $-0.16 | $0.38 |
| Sorpresa | — | +233.3% | +25.0% | +18.4% |
| Métrica | VCEL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 74.4% | 57.0% | +17.4% |
| Operating Margin | 4.0% | -38.6% | +42.6% |
| Net Margin | 6.0% | -33.6% | +39.5% |
| FCF Margin | 9.0% | -13.9% | +22.8% |
| ROE | 4.7% | -40.4% | +45.1% |
| ROA | 3.4% | -32.0% | +35.4% |
| Current Ratio | 5.03 | 2.84 | +2.19 |
| Debt / Equity | — | 0.28 | — |